Your cart is currently empty!

Atomfair Sonlicromanol KH-176, KH176 C19H28N2O3
Description Sonlicromanol (CAS No. 1541170-75-5) is a high-purity small molecule with the molecular formula C19H28N2O3, and IUPAC name (2S)-6-hydroxy-2,5,7,8-tetramethyl-N-[(3R)-piperidin-3-yl]-3,4-dihydrochromene-2-carboxamide . This compound, also known by its developmental code KH-176 , is a redox-modulating agent under investigation for its therapeutic potential in mitochondrial disorders. It exhibits high stability and solubility profiles, making it suitable for in vitro and in vivo research applications. Our product is rigorously tested via HPLC, NMR, and mass spectrometry to ensure ??98% purity, meeting the stringent requirements of pharmaceutical and biochemical research. Available in milligram to gram quantities with custom bulk options.
Description
Description
Sonlicromanol (CAS No. 1541170-75-5) is a high-purity small molecule with the molecular formula C19H28N2O3, and IUPAC name (2S)-6-hydroxy-2,5,7,8-tetramethyl-N-[(3R)-piperidin-3-yl]-3,4-dihydrochromene-2-carboxamide. This compound, also known by its developmental code KH-176, is a redox-modulating agent under investigation for its therapeutic potential in mitochondrial disorders. It exhibits high stability and solubility profiles, making it suitable for in vitro and in vivo research applications. Our product is rigorously tested via HPLC, NMR, and mass spectrometry to ensure ??98% purity, meeting the stringent requirements of pharmaceutical and biochemical research. Available in milligram to gram quantities with custom bulk options.
- CAS No: 1541170-75-5
- Molecular Formula: C19H28N2O3
- Molecular Weight: 332.4
- Exact Mass: 332.20999276
- Monoisotopic Mass: 332.20999276
- IUPAC Name: (2S)-6-hydroxy-2,5,7,8-tetramethyl-N-[(3R)-piperidin-3-yl]-3,4-dihydrochromene-2-carboxamide
- SMILES: CC1=C(C2=C(CC[C@@](O2)(C)C(=O)N[C@@H]3CCCNC3)C(=C1O)C)C
- Synonyms: Sonlicromanol, KH-176, JCU3O35RDS, UNII-JCU3O35RDS, KH176
Application
Sonlicromanol (KH-176) is a promising redox modulator studied for its potential in treating mitochondrial diseases, such as Leigh syndrome and MELAS (Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes). It targets oxidative stress by balancing cellular redox states, making it relevant for neurodegenerative and metabolic disorder research. Preclinical studies suggest neuroprotective and energy-restoring effects, supporting further investigation in mitochondrial dysfunction models.
If you are interested or have any questions, please contact us at support@atomfair.com